Navigation Links
Unknown Facts About Chronic Low Back Pain Treatment Revealed by the Experts
Date:1/22/2013

Sturgeon Bay, WI (PRWEB) January 22, 2013

When the muscle relaxers, anti-inflammatories, and pain killers fail, many victims of chronic low back pain turn to surgery. Spinal surgery has been accepted as the final solution, but is this very expensive procedure effective? Sturgeon Bay, Wisconsin Chiropractor and Naturopath Dr. J G Moellendorf, DC, ND, LCP, reports on recent research published in the December 2012 issue of the European Spine Journal which looked into this very question.

Researchers led by Dr. Anne Froholdt of the Oslo University Hospital in Oslo, Norway did a 9 year follow-up of patients with chronic low back pain. Patients were randomly assigned to one of two groups. The first group had spinal fusion at L4/L5 and/or L5/S1 with screws and bone transplantation. The second group received cognitive training to teach the patients how to participate in daily activities such as vacuum cleaning, ironing, gardening, etc. without worrying about causing further harm, along with endurance and coordination exercises. Primary results were measured with the Oswestry Disability Index, while secondary results considered pain, fear-avoidance beliefs, spinal muscle strength, use of medication, and ability to return to work.

After nine years, one-third of the patients in the non-surgery group opted to have surgery done. Of those in the first group
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Aviir, Inc.s CEO Dr. Douglas Harrington Delivered The Facts Surrounding Heart Disease At The Los Angeles Ultimate Womens Expo
2. U.S. Potato Industry Hears About Consumer Trends and Growth Opportunities at POTATO EXPO 2013
3. The Leading Edge Of Medical Innovation: New Prenatal Genetic Tests Use Moms Blood To Learn About Her Baby
4. Career Confidential Announces Release of New E-book About Using Recruiters
5. UCSB researchers demonstrate that 15=3x5 about half of the time
6. Laboratory Decision Makers Cautiously Optimistic about Funding Conditions, Finds Frost & Sullivan
7. "Just Label It" condemns dangerous riders snuck into the Farm Bill by chemical companies working to keep Americans in the dark about their food
8. July is not just about BBQ's; the Arthritis National Research Foundation honors Juvenile Arthritis Awareness Month
9. Physicians Answer Questions About Food Biotechnology in IFIC Foundation Videos
10. UAS Laboratories Presents about Probiotic Selection Criteria, at Scientific Conference
11. Decades-old conclusion about energy-making pathway of cyanobacteria is corrected
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... Feb. 26, 2015  Spark Therapeutics (NASDAQ: ONCE ... will participate in the Cowen and Company Health Care ... Eastern, at the Boston Marriott Copley Place. ... presentation from the Cowen conference, please visit the "Upcoming ... the Spark Therapeutics website at www.sparktx.com .  A ...
(Date:2/26/2015)... (PRWEB) February 26, 2015 On Wednesday, ... to building a nationwide Clostridium difficile (C. diff) awareness ... diff burden study by the Centers for Disease Control ... caused almost half a million infections among Americans in ... nursing homes. , The study also estimates that ...
(Date:2/26/2015)... LONDON , February 26, 2015 ... of subjects into PEACH, the first pivotal trial ... dialysis dependent chronic kidney disease (DD-CKD), has completed ... achieved. PT20, invented by leading UK-based ... licensed by Phosphate Therapeutics, is a novel phosphate ...
(Date:2/25/2015)... , Feb. 25, 2015 truBrain ... is featured in this week,s Power Pitch segment ... to discuss the company,s traction and growth strategy, ... the crowd funding site CircleUp. The ... that are validated by neurotechnology, while also discussing ...
Breaking Biology Technology:Spark Therapeutics to Participate in the 35th Annual Cowen and Company Health Care Conference 2Peggy Lillis Foundation Lauds CDC's New, More Comprehensive Study on the Burden of C. difficile Infections in the United States 2Peggy Lillis Foundation Lauds CDC's New, More Comprehensive Study on the Burden of C. difficile Infections in the United States 3Peggy Lillis Foundation Lauds CDC's New, More Comprehensive Study on the Burden of C. difficile Infections in the United States 4Phosphate Therapeutics Announces Completion of Subject Recruitment Into the PEACH Pivotal Phase 2 Study of its Novel Phosphate Binder (PT20) for the Treatment of Hyperphosphataemia 2Phosphate Therapeutics Announces Completion of Subject Recruitment Into the PEACH Pivotal Phase 2 Study of its Novel Phosphate Binder (PT20) for the Treatment of Hyperphosphataemia 3CNBC's Power Lunch Features Neurotechnology Start-up truBrain 2
... ... the upside of not only producing a low sodium meat product but with better ... ... of value-added ingredients into the natural food, nutraceutical and medical food market, is proud ...
... ... ... ... ...
... ... ... ... ...
Cached Biology Technology:New Study Shows Nu-Tek's Modified Potassium Chloride Improves Yields in Meat Processing 2New Study Shows Nu-Tek's Modified Potassium Chloride Improves Yields in Meat Processing 3Medivation to Host Conference Call at 8:30 a.m. Eastern Time Tomorrow to Discuss Phase 3 Trial Results for Dimebon in Alzheimer's Disease 2Medivation to Host Conference Call at 8:30 a.m. Eastern Time Tomorrow to Discuss Phase 3 Trial Results for Dimebon in Alzheimer's Disease 3Zenith Biotech Introducing Novel StemQ(R) Hepatic and Neural Models for Use in Drug Discovery, Metabolism and Toxicology Studies, at The 49th Annual Meeting and ToxExpo In Salt Lake City, Utah, March 7-11, 2010, Booth #136 2Zenith Biotech Introducing Novel StemQ(R) Hepatic and Neural Models for Use in Drug Discovery, Metabolism and Toxicology Studies, at The 49th Annual Meeting and ToxExpo In Salt Lake City, Utah, March 7-11, 2010, Booth #136 3Zenith Biotech Introducing Novel StemQ(R) Hepatic and Neural Models for Use in Drug Discovery, Metabolism and Toxicology Studies, at The 49th Annual Meeting and ToxExpo In Salt Lake City, Utah, March 7-11, 2010, Booth #136 4Zenith Biotech Introducing Novel StemQ(R) Hepatic and Neural Models for Use in Drug Discovery, Metabolism and Toxicology Studies, at The 49th Annual Meeting and ToxExpo In Salt Lake City, Utah, March 7-11, 2010, Booth #136 5Zenith Biotech Introducing Novel StemQ(R) Hepatic and Neural Models for Use in Drug Discovery, Metabolism and Toxicology Studies, at The 49th Annual Meeting and ToxExpo In Salt Lake City, Utah, March 7-11, 2010, Booth #136 6Zenith Biotech Introducing Novel StemQ(R) Hepatic and Neural Models for Use in Drug Discovery, Metabolism and Toxicology Studies, at The 49th Annual Meeting and ToxExpo In Salt Lake City, Utah, March 7-11, 2010, Booth #136 7
(Date:2/5/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD and ... focused on the growing mobile commerce market, announces it ... Conference on January 29 th at 10:30 a.m. ... of NXT-ID will present and host a live Q&A ... and its full suite of biometric technologies. Investors can ...
(Date:1/22/2015)... 2015 Valid S.A. ("Company") (BM&FBOVESPA: VLID3 ON), is pleased ... State of Washington,s Department of Licensing, ... and central issuance system for driver,s licenses and identification cards ... planning and development will start in January 2015, with enrollment ...
(Date:1/22/2015)... man-made form of insulin delivered by nasal spray may ... with mild cognitive impairment and Alzheimer,s disease dementia, according ... Forest Baptist Medical Center. The study,s subjects ... (MCI) or mild to moderate Alzheimer,s dementia (AD). Those ...
Breaking Biology News(10 mins):CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3Valid USA Signs Contract For Washington Driver's License Issuance 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3
... people are annoyed by upspeak: the habit of making a sentence ... intonation in speech as in upspeak may be a ... PLoS ONE finds that people use the same brain ... suggest that people learn by imitating through so-called mirror neurons. This ...
... Led by Professor Gail Taylor, an expert on plants ... of scientists across the UK will track the path of ... photosynthesis, as it flows through the plant to the soil, ... matter in the soil in which the plant is growing. ...
... by emphysema and/or chronic bronchitis. It destroys the ... aspects of breathing, which prevents necessary gas exchange. ... of lung infections. These symptoms are associated with ... air sacs, which usually inflate with air during breathing ...
Cached Biology News:Music in speech equals empathy in heart? 2Solutions to climate change: Using trees and grasses to capture carbon and produce energy 2New potential to treat chronic obstructive pulmonary disease 2